TABLE 3.

Evaluation for synergy of combinations consisting of either tobramycin or ciprofloxacin and mitomycin C against ASS of P. aeruginosa, A. baumannii, and E. coli.

Organism	MICMitomycin C [MICcombo], μg/mL	Adjuvant	MICAdjuvant [MICcombo], μg/mL	FIC index	Interpretation
P. aeruginosa PAO1	2 [1]	Tobramycin	1 [0.25]	0.750	Additive
A. baumannii ATCC 17978	16 [8]		1 [0.25]	0.750	Additive
E. coli ATCC 25922	0.25 [0.125]		2 [0.25]	0.625	Additive
P. aeruginosa PAO1	2 [1]	Ciprofloxacin	0.125 [0.031]	0.750	Additive
A. baumannii ATCC 17978	16 [8]		0.5 [0.125]	0.750	Additive
E. coli ATCC 25922	0.25 [0.25]		0.016 [0.002]	1.125	Additive